Cutting edge:: TLR ligands are not sufficient to break cross-tolerance to self-antigens

被引:52
作者
Hamilton-Williams, EE
Lang, A
Benke, D
Davey, GM
Wiesmüller, KH
Kurts, C [1 ]
机构
[1] Univ Bonn, Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany
[2] Rhein Westfal TH Aachen Hosp, Dept Nephrol & Clin Immunol, Aachen, Germany
[3] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[4] Univ Tubingen, Inst Organ Chem, Tubingen, Germany
关键词
D O I
10.4049/jimmunol.174.3.1159
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cross-presentation of peripheral self-Ags by dendritic cells (DC) can induce deletion of autoreactive CTL by a mechanism termed cross-tolerance. Activation of DC by microbial TLR ligands is thought to result in adaptive immunity. However, activation of tolerogenic DC may cause autoimmunity by stimulating instead of deleting autoreactive CTL. To investigate this scenario, we have monitored the response of autoreactive CTL in specific for the transgenic self Ag, OVA, expressed in pancreatic islets of RIP-mOVA mice injected with ligands of TLR2, 3, 4, and 9. This somewhat enhanced proliferation and cytokine production, and moderately reduced the CTL number able to induce autoimmunity. Nevertheless, physiological CTL numbers were deleted before disease ensued, unless was provided. In conclusion, DC specific CD4 T cell help activation by TLR ligands was insufficient to break peripheral cross-tolerance in the absence of specific CD4 T cell help, and triggered autoimmunity by stimulating the early effector phase of autoreactive CTL only when their precursor frequency was extremely high.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 26 条
[1]   Toll-like receptors and innate immunity [J].
Akira, S .
ADVANCES IN IMMUNOLOGY, VOL 78, 2001, 78 :1-56
[2]   Checkpoints in the progression of autoimmune disease: Lessons from diabetes models [J].
Andre, I ;
Gonzalez, A ;
Wang, B ;
Katz, J ;
Benoist, C ;
Mathis, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2260-2263
[3]   MULTIPLE LEVELS OF PERIPHERAL TOLERANCE [J].
ARNOLD, B ;
SCHONRICH, G ;
HAMMERLING, GJ .
IMMUNOLOGY TODAY, 1993, 14 (01) :12-14
[4]   Helper requirements for generation of effector CTL to islet β cell antigens [J].
Behrens, GMN ;
Li, M ;
Davey, GM ;
Allison, J ;
Flavell, RA ;
Carbone, FR ;
Heath, WR .
JOURNAL OF IMMUNOLOGY, 2004, 172 (09) :5420-5426
[5]  
BEUDER B, 2004, NATURE, V430, P257
[6]   Helping the CD8+ T-cell response [J].
Bevan, MJ .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (08) :595-602
[7]   Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient [J].
Christen, U ;
Benke, D ;
Wolfe, T ;
Rodrigo, E ;
Rhode, A ;
Hughes, AC ;
Oldstone, MBA ;
von Herrath, MG .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (01) :74-84
[8]  
den Boer AT, 2001, J IMMUNOL, V167, P2522
[9]   Cross-presentation, dendrttic cells, tolerance and immunity [J].
Heath, WR ;
Carbone, FR .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :47-64
[10]   Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells [J].
Heit, A ;
Maurer, T ;
Hochrein, H ;
Bauer, S ;
Huster, KM ;
Busch, DH ;
Wagner, H .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :2802-2805